Technical Articles

KRAS WT & cRAF Binding Kit

Molecular characteristics and clinical significance of KRAS wild-type pancreatic cancer tumors

2026-02-28

Pancreatic ductal adenocarcinoma is one of the most malignant tumors in the digestive system, with a 5-year survival rate consistently below 10%. KRAS gene mutation is the earliest and most common driving event in the development and progression of PDAC.

View details

Cancer
KRAS WT & cRAF Binding Kit
Pancreatic ductal adenocarcinoma
Tumor

Total 1

Go to